Literature DB >> 32180583

Evaluation of prognostic factors for 5 year-survival after surgery for colorectal cancer.

Bogdan V Micu, Ştefan C Vesa, Tudor Radu Pop, Carmen M Micu.   

Abstract

AIM: The aim of this study was to assess and analyze the prognostic factors for survival in patients undergoing curative surgery for colorectal cancer and to identify new prognostic factors.
METHODS: The prospective study included 301 patients diagnosed with colorectal cancer, stages I-III, undergoing curative surgery. Demographic data, clinical and anamnestic data, laboratory exams, paraclinical examinations, morphological and pathological examination were recorded. The Petersen index was calculated. Tumor necrosis, desmoplasia and mucinous component were assessed. Local inflammatory response was calculated using Klintrup criteria. Patients were followed for five years after surgery.
RESULTS: There were 197 patients (66.4%) who survived and 104 patients (34.6%) who died during the 5-year follow- up period. Multivariate analysis showed that death was mostly associated with patients over 60 years of age (p=0.05). Tumor location within the colon was associated with a better survival than tumor location within the rectum (HR - 0.57; p=0.02). Patients with T>2 had a poor prognosis compared to those with T=<2 (HR - 2.23; p=0.02). Patients with Klintrup score >1 had a better prognosis (HR - 0.20; p <0.001). Patients with venous invasion showed significantly worse prognosis (HR - 2.26; p=0.003). Patients with desmoplasia score 3 had lower death rates than those with score 1 (HR - 0.42; p=0.01).
CONCLUSION: Survival was superior in patients with cancer of the colon. The following parameters had a strong independent prognostic factor for survival: age, stage T>2, venous invasion, mucinous component and desmoplasia. KEY WORDS: Colorectal cancer, Prognostic factors, Survival.

Entities:  

Mesh:

Year:  2020        PMID: 32180583

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  7 in total

1.  Sevoflurane Suppresses the Proliferation, Migration and Invasion of Colorectal Cancer Through Regulating Circ_0000423/miR-525-5p/SGPP1 Network.

Authors:  Xiaofang Kang; Xiaocong Li; Yanli Li
Journal:  Cell Mol Bioeng       Date:  2022-01-22       Impact factor: 2.321

2.  Analysis of ARHGAP4 Expression With Colorectal Cancer Clinical Characteristics and Prognosis.

Authors:  Ming-Sheng Fu; Shu-Xian Pan; Xun-Quan Cai; Yuan-Xin Hu; Wei-Jie Zhang; Qin-Cong Pan
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

3.  Predictors of Quality of Life Six Years after Curative Colorectal Cancer Surgery: Results of the Prospective Multicenter Study.

Authors:  Gintare Valeikaite-Tauginiene; Agne Kraujelyte; Eligijus Poskus; Valdemaras Jotautas; Zilvinas Saladzinskas; Algimantas Tamelis; Paulius Lizdenis; Audrius Dulskas; Narimantas Evaldas Samalavicius; Kęstutis Strupas; Tomas Poškus
Journal:  Medicina (Kaunas)       Date:  2022-03-26       Impact factor: 2.948

4.  Clinical Significance of Preoperative Inflammatory Markers in Prediction of Prognosis in Node-Negative Colon Cancer: Correlation between Neutrophil-to-Lymphocyte Ratio and Poorly Differentiated Clusters.

Authors:  Giulia Turri; Valeria Barresi; Alessandro Valdegamberi; Gabriele Gecchele; Cristian Conti; Serena Ammendola; Alfredo Guglielmi; Aldo Scarpa; Corrado Pedrazzani
Journal:  Biomedicines       Date:  2021-01-19

5.  Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.

Authors:  Fu Ming-Sheng; Du Mei-Ling; Cai Xun-Quan; Hu Yuan-Xin; Zhang Wei-Jie; Pan Qin-Cong
Journal:  Can J Gastroenterol Hepatol       Date:  2022-01-04

6.  Identification of Six Genes as Diagnostic Markers for Colorectal Cancer Detection by Integrating Multiple Expression Profiles.

Authors:  Peijie Wu; Xiuqing Yang; Ling Qiao; Yanju Gong
Journal:  J Oncol       Date:  2022-07-22       Impact factor: 4.501

7.  miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X.

Authors:  Shusen Xia; Xianyan Wang; Yi Wu; Tong Zhou; Hongpeng Tian; Zuoliang Liu; Lifa Li; Zaihua Yan; Guangjun Zhang
Journal:  Dis Markers       Date:  2022-08-25       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.